Literature DB >> 10573181

Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding.

M Geurts1, E Hermans, J M Maloteaux.   

Abstract

The dopamine receptor-mediated modulation of guanosine 5'-O-(gamma-[35S]thio)triphosphate ([35S]GTP gamma S) binding has been characterized in rat striatal membranes. In optimized experimental conditions, the potency of dopamine was 4.47 microM [3.02-6.61 microM] and a maximal response representing 54.8 +/- 4.5% increase above basal level was observed. Data obtained with different agonists and antagonists clearly revealed that the most important fraction of this response was reflecting D2 receptor activation. Further analysis with specific antagonists also supported evidence for the involvement of D1 dopamine receptors. The potencies of compounds interacting with D1 and D2 receptors were deduced from [35S]GTP gamma S binding experiments and compared with their binding affinities for these receptors measured in similar experimental conditions. A good correlation between these parameters was observed, supporting the applicability of this technique for the study of dopamine receptors in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573181     DOI: 10.1016/s0024-3205(99)00412-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.

Authors:  Beryl Koener; Stéphanie Goursaud; Morgane Van De Stadt; André-Guilhem Calas; Anne P Jeanjean; Jean-Marie Maloteaux; Emmanuel Hermans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01       Impact factor: 3.000

2.  Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.

Authors:  Francesco Napolitano; Massimo Pasqualetti; Alessandro Usiello; Emanuela Santini; Giulia Pacini; Giuseppe Sciamanna; Francesco Errico; Annalisa Tassone; Valeria Di Dato; Giuseppina Martella; Dario Cuomo; Gilberto Fisone; Giorgio Bernardi; Georgia Mandolesi; Nicola B Mercuri; David G Standaert; Antonio Pisani
Journal:  Neurobiol Dis       Date:  2010-03-19       Impact factor: 5.996

3.  D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Ho-Joo Lee; Richard P Bazinet; Ruth Seemann; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

4.  Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.

Authors:  Niklas Lindgren; Alessandro Usiello; Michel Goiny; John Haycock; Eric Erbs; Paul Greengard; Tomas Hokfelt; Emiliana Borrelli; Gilberto Fisone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

5.  The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum.

Authors:  Diego Centonze; Silvia Rossi; Ilaria Napoli; Valentina Mercaldo; Caroline Lacoux; Francesca Ferrari; Maria Teresa Ciotti; Valentina De Chiara; Chiara Prosperetti; Mauro Maccarrone; Filomena Fezza; Paolo Calabresi; Giorgio Bernardi; Claudia Bagni
Journal:  J Neurosci       Date:  2007-08-15       Impact factor: 6.167

6.  Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia.

Authors:  Iker Egusquiza; Eva Munarriz-Cuezva; Rafael Segarra; Javier González-Maeso; Luis F Callado; J Javier Meana; Rebeca Diez-Alarcia
Journal:  Pharmacol Rep       Date:  2021-07-01       Impact factor: 3.024

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.